Stanford Medicine and the Department of Veterans Affairs will work together to establish the U.S’s first Hadron Center in Palo Alto, Calif. that will work to offer Hadron therapy to both veteran and non-veteran cancer patients.
The VA said Monday it has maintained academic and research affiliations with Stanford Medicine and the partnership looks to expand collaboration through the Hadron Center and particle beam therapy for cancer patients.
The Hadron Center clinical facility will be designed to provide particle radiation beam therapy for treatments of cancer patients and offer access to clinical trials in support of the VA Palo Alto Health Care System’s mission to offer care for veterans.
Lloyd Minor, dean of Stanford University’s school of medicine, said the school has committed to provide personalized healthcare tailored to each individual.
“We seek to identify optimal ways to offer targeted treatment that both reduces harm and promotes healing,” he added.
The VA noted the Prostate Cancer Foundation has also contributed $50 million to the department to support precision oncology research and the two organizations will host a national oncology summit called “Launch Pad: Pathways to InnoVAtion” in November.